24小时热门版块排行榜    

查看: 1996  |  回复: 9

xiangf

金虫 (小有名气)

[求助] Nexplanon的专利帮忙找找~~~~~~~~~~

Merck公司近日表示在美国上市68mg的Nexplanon (etonogestrel、依托孕烯) 皮下植入棒式避孕药。

这个避孕药的专利找不到,请高手们帮帮忙!!
回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐,对您同样有帮助:

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hnsqwxp

木虫 (正式写手)

药剂科学家

【答案】应助回帖

感谢参与,应助指数 +1
楼主是要美国专利还是中国专利,是化合物专利还是制剂专利呢。
2楼2011-12-23 15:55:09
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

xiangf

金虫 (小有名气)

引用回帖:
: Originally posted by hnsqwxp at 2011-12-23 15:55:09:
楼主是要美国专利还是中国专利,是化合物专利还是制剂专利呢。

是这个产品的制剂专利,国内外的都可以,国内的为佳。
谢谢!
3楼2011-12-23 16:04:49
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

xiangf

金虫 (小有名气)

引用回帖:
: Originally posted by hnsqwxp at 2011-12-23 15:55:09:
楼主是要美国专利还是中国专利,是化合物专利还是制剂专利呢。

是这个商品对应的制剂专利,就是这个皮肤下植入剂的专利,其他的制剂不要,谢谢!
4楼2011-12-23 16:05:56
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hnsqwxp

木虫 (正式写手)

药剂科学家

【答案】应助回帖

★ ★
豆哥(金币+2): 感谢参与交流 2011-12-24 09:24:38
Intrauterine system for retaining and releasing therapeutically effective dose of e.g. biologically active compound within uterus of human for treatment of e.g. menorraghia, has retention elements retaining frame within uterus of mammal
专利号: US2010280464-A1   ; WO2010128004-A1  
发明人:        DE GRAAFF W, VEENSTRA H, MARTINE T M T, MULDERS T M T
专利权人和代码:ORGANON NV(ORGA-C)
Derwent 主入藏号: 2010-N76468 [79]
被审查员引用的专利: 6       
摘要: NOVELTY - The system (200) has a deposit i.e. rod-shaped deposit, of a therapeutically effective dose of a biologically active compound. A frame defines an interior space for receipt of the deposit, where the frame has an open structure allowing access to a part of an outer surface of the deposit. Multiple retention elements retain the frame within a uterus of a female mammal. The frame interacts with the deposit to form a mechanical structure having a bending stiffness greater than the sum of that of the frame and deposit taken individually.

USE - Intrauterine system for retaining and releasing a therapeutically effective dose of a biologically active compound within uterus of female mammal i.e. human, for treatment of a medical condition e.g. dysfunctional uterine bleeding, menorraghia, dysmenorrhoea, endometriosis, uterine fibroids, climacteric complaints, osteoporosis and urogenital atrophy (all claimed). Uses include but are not limited to nomegestrol acetate (NOMAc), natural progesterone, levonogestrel, etonogestrel, dydrogesterone, medrogestone, medroxyprogesterone acetate, megestrol acetate, chlormadinone acetate and cyproterone acetate.

ADVANTAGE - The part of the outer surface of the deposit is directly exposed to an environment due to the open structure of the frame, so that the rate controlling effect on a steady state release of the compound to the uterus can be primarily determined by the structure of the deposit and the environment in which the structure is placed, thus enabling relatively easy prediction of release rates within the frame. The flexible frame and the deposit interact to form a composite mechanical structure, so that the system has greater mechanical strength such as bending stiffness, thus achieving an improved structure that ensures adequate strength while ensuring ease of insertion due to the small cross-section of the frame.

详细说明 - INDEPENDENT CLAIMS are also included for the following:

(1) a method for manufacturing an intrauterine system

(2) a method for treating a female mammal.

附图说明 - The drawing shows a perspective view of an intrauterine system prior to assembly.

Intrauterine system (200)

Stem (204)

Frame halves (205, 205')

Living hinges (207, 207')

Snap elements (209)

显示文献摘要
附图:

国际专利分类:        A61M-037/00; B23P-011/00; A61F-006/00; A61F-006/14; A61K-009/00
德温特分类代码:        A96 (Medical, dental, veterinary, cosmetic); B07 (General - tablets, dispensers, catheters); B01 (Steroids including systems with rings fused to basic steroid structure); P34 (Sterilising, syringes, electrotherapy); P56 (Machine tools)
德温特手工代码:        A11-B07; A12-V03D; B01-C03; B01-C04; B01-C05; B11-C03; B11-C04; B12-M10; B12-M12L; B14-D01B; B14-D01C; B14-F08; B14-H05; B14-N01A; B14-N07; B14-N14; B14-S18
专利详细信息:
专利号        公开日期        主 IPC        周        页数        语种
US2010280464-A1         04 Nov 2010        A61M-037/00        201079         Pages: 11         English
WO2010128004-A1         11 Nov 2010        A61F-006/14        201079                  English
申请详细信息:
US2010280464-A1         US770105         29 Apr 2010
WO2010128004-A1         WOEP055948         03 May 2010
优先权申请信息和日期:
EP159353         04 May 2009
指定国家 (地区)/区域:
WO2010128004-A1:
     国家 (地区): AE; AG; AL; AM; AO; AT; AU; AZ; BA; BB; BG; BH; BR; BW; BY; BZ; CA; CH; CL; CN; CO; CR; CU; CZ; DE; DK; DM; DO; DZ; EC; EE; EG; ES; FI; GB; GD; GE; GH; GM; GT; HN; HR; HU; ID; IL; IN; IS; JP; KE; KG; KM; KN; KP; KR; KZ; LA; LC; LK; LR; LS; LT; LU; LY; MA; MD; ME; MG; MK; MN; MW; MX; MY; MZ; NA; NG; NI; NO; NZ; OM; PE; PG; PH; PL; PT; RO; RS; RU; SC; SD; SE; SG; SK; SL; SM; ST; SV; SY; TH; TJ; TM; TN; TR; TT; TZ; UA; UG; US; UZ; VC; VN; ZA; ZM; ZW
化合物
DCR 号        特征描述        DCR 号        特征描述        DCR 号        特征描述
102210-1-0-0        (K M)        6478-1-0-0        (K M)        94705-1-0-0        (K M)
13759-2-0-0        (K M)        100334-1-0-0        (K M)        100338-1-0-0        (K M)
100358-1-0-0        (K M)        90738-1-0-0        (K M)        166768-1-0-0        (K M)
102310-2-0-0        (K M)
环系索引号:
10975
Derwent 化合物号:
化合物号        特征描述        化合物号        特征描述        化合物号        特征描述
R19407        (K M)        R00145        (K M)        RA2UMU        (K M)
R15326        (K M)        RA24UQ        (K M)        R00308        (K M)
R12004        (K M)        R01209        (K M)        R01250        (K M)
R04886        (K M)        R13690        (K M)
Derwent 注册号:
注册号        特征描述        注册号        特征描述        注册号        特征描述
0145        (S)        0308        (S)        1209        (S)
1250        (S)

这个是DII查到的信息,,wo专利里指定了CN的哦。

» 本帖已获得的红花(最新10朵)

5楼2011-12-23 16:07:28
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hnsqwxp

木虫 (正式写手)

药剂科学家

【答案】应助回帖

你仔细看看是不是这个,我大概看了下貌似是这个。
http://worldwide.espacenet.com/p ... om&locale=en_EP
上面的链接是欧专局上的同族信息。
6楼2011-12-23 16:13:00
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

xiangf

金虫 (小有名气)

送鲜花一朵
引用回帖:
: Originally posted by hnsqwxp at 2011-12-23 16:07:28:
Intrauterine system for retaining and releasing therapeutically effective dose of e.g. biologically active compound within uterus of human for treatment of e.g. menorraghia, has retention elements  ...

Nexplanon是植入上臂内侧,其可持续低量稳定的释放依托孕烯达到避孕作用。
是Nexplanon对应的专利哦,谢谢你的支持。
7楼2011-12-23 16:17:51
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hnsqwxp

木虫 (正式写手)

药剂科学家

【答案】应助回帖

(0)       保存为:       更多选项
Kit for assembling disposable applicator used for inserting implant containing active substance under skin of human or animal, has two components including housing with rod being mountable inside cannula and cannula holder
专利号: WO2007082889-A1   ; NO200802754-A ; AU2007206957-A1 ; EP1984063-A1   ; US2009012463-A1   ; KR2008092386-A ; CN101370550-A ; ZA200805243-A ; CA2636145-A1 ; MX2008009009-A1 ; JP2009523515-W ; IN200803712-P4 ; NZ569202-A ; BR200706472-A2
发明人:        BEELEN D C F, VAN HARMELEN M, MOORMANN R T, TAK M P W, MOORMANN R T M, BEELEN D, MOORMANN R, TAK M, HARMELEN M V
专利权人和代码:ORGANON NV(ORGA-C)
Derwent 主入藏号: 2007-526746 [39]
被审查员引用的专利: 10       
摘要: NOVELTY - The kit (1) has a component (4) containing a main housing (5,6) with a handle (7) for grasping and manoeuvring an applicator, a cannula and a cannula holder. The cannula holder is mounted in the main housing that contains an opening for allowing introduction of an implant (3) into its end or an end of cannula. Another component (8) with a housing (9) is provided for closing the opening. The housing is complementary to main housing. A rod (10) is attached to the housing forming an integral region within it. The rod is mountable inside cannula and cannula holder.

USE - For assembling disposable applicator (claimed) used for inserting implant such as rod-like implant, etc., containing active substance under the skin of human or animal. Also for single rod contraceptive implant for releasing substance such as progestogenic hormone e.g. etonogestrel through rod into human body for protection against pregnancy for extended period such as three years.

ADVANTAGE - The risk of damaging the delicate implant during its introduction into the cannula and the cannula holder can be reduced effectively.
看下这个专利,,上面的我仔细看下确实不是,这个好像是。
8楼2011-12-23 16:28:35
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hnsqwxp

木虫 (正式写手)

药剂科学家

【答案】应助回帖

xiangf(金币+10): ★★★★★最佳答案 应该是这个,没想到最后居然是个装置。晕死了 2011-12-23 17:12:12
9楼2011-12-23 16:43:42
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

xiangf

金虫 (小有名气)

引用回帖:
: Originally posted by hnsqwxp at 2011-12-23 16:43:42:
http://www.soopat.com/Home/Resul ... 50&LeiXing=

真是太强悍了,这是怎么查到的。
10楼2011-12-23 17:13:09
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 xiangf 的主题更新
信息提示
请填处理意见